Likewise, V158411 potentiated gemcitabine cytotoxicity in p53 mutant, but not wild type, TNBC and ovarian cancer cell lines [78] and in a panel of p53 mutant colon, lung and prostate cancer cell lines, whereas unmatched p53 proficient cell lines were unaffected [57]. Here, TP53 is linked to ovarian carcinoma.